ReviewCurrent oncology (Toronto, Ont.)2019

Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma.

P Skrabek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.